Overweight: Clinical Trials

13,727 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8560 completed, 1670 unknown, 1356 recruiting, 614 active not recruiting. 8078 Not applicable, 972 Phase 2, 796 Phase 1, 677 Phase 3, 588 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8078Completed 5252, Unknown 983, Recruiting 704, Active not recruiting 343, Not yet recruiting 298, Terminated 263, Withdrawn 157, Enrolling by invitation 66, Suspended 12
Phase 2972Completed 605, Recruiting 98, Unknown 66, Active not recruiting 58, Terminated 58, Not yet recruiting 44, Withdrawn 37, Enrolling by invitation 3, Suspended 3
Phase 1796Completed 516, Recruiting 104, Active not recruiting 50, Not yet recruiting 41, Unknown 34, Terminated 32, Withdrawn 17, Enrolling by invitation 1, Suspended 1
Phase 3677Completed 379, Recruiting 94, Unknown 58, Active not recruiting 48, Terminated 46, Not yet recruiting 33, Withdrawn 16, Suspended 2, Enrolling by invitation 1
Phase 4588Completed 335, Unknown 81, Recruiting 52, Not yet recruiting 37, Terminated 33, Active not recruiting 25, Withdrawn 20, Enrolling by invitation 4, Suspended 1
Early Phase 1123Completed 66, Unknown 16, Recruiting 13, Withdrawn 9, Active not recruiting 5, Not yet recruiting 5, Terminated 5, Suspended 3, Enrolling by invitation 1

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
Polylactose, Placebo - Obesity, Adolescent, Obesity, Childhood
Not applicableWithdrawnUniversity of Minnesota2028-05-012025-07-11
A Study of Body Fat Distribution and Airway Mechanics in Healthy Adults
Body positioning - Healthy Volunteers Only
Not applicableNot yet recruitingMaurizio F. Cereda, MD202028-01-012025-06-18
Adiposity Distribution in Acute Respiratory Failure
PEEP Titration Using Electrical Impedance Tomography (EIT), Body Positioning: Supine and Prone - Acute Hypoxemic Respiratory Failure, Obesity
Not applicableNot yet recruitingMaurizio F. Cereda, MD802028-01-012025-06-13
Community Active and Healthy Families Pragmatic Trial
Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment - Child Obesity
Phase 4Not yet recruitingUniversity of Colorado, Denver4162028-01-012026-10-09
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Tirzepatide + Standard Therapy (Intervention Group), Standard Oral Antidiabetic Drugs (OADs) - Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Not applicableNot yet recruitingAkhtar Saeed Medical and Dental College522027-12-122026-10-29
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
AI-informed behavioral intervention, Standard behavioral intervention, Health Education - Obesity (Disorder)
Not applicableNot yet recruitingAikaterini Karaivazoglou8402027-09-012026-04-14
Modifying Diet to Improve Gut Microbiome
DASH diet, standard American diet - Obesity
Not applicableNot yet recruitingH. Lee Moffitt Cancer Center and Research Institute282027-07-012026-09-17
Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs
Intranasal Oxytocin 40 i.u., Intranasal Placebo Spray - Obesity & Overweight, Respiratory Depression
Phase 2Not yet recruitingGeorge Washington University1002027-05-152026-10-29
Simplifying Diet Tracking in a Digital Weight Loss Intervention
Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention - Overweight, Obesity
Not applicableNot yet recruitingStanford University3282027-05-012026-05-28
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Not applicableNot yet recruitingBoston Scientific Corporation502027-04-012026-11-06
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
NutriAct plus, Rescue VLCD - Obesity & Overweight, Weight Loss Maintenance
Not applicableNot yet recruitingKnut Mai2922027-03-012026-07-20
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
Pecan, Control - Nutrition, Healthy, Dyslipidemia
Not applicableNot yet recruitingUniversity of Georgia902027-03-012026-08-11
Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer
Semaglutide (Wegovy®) - Breast Cancer (Early Breast Cancer), Obesity
Phase 2Not yet recruitingAarhus University Hospital322027-03-012026-11-02
Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity
Semaglutide - Pediatric Obesity, Obesity
Not yet recruitingErin Mauney122027-03-012026-11-02
Puerto Rican Obesity Intervention for Men
TeleSalud Healthy Eating- Physical Activity/Sedentary Behavior (HE-PA/SB), TeleSalud General Health Intervention - Obesity
Not applicableNot yet recruitingMedical College of Wisconsin482027-03-012026-10-30
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
LUM-201, Placebo, Semagludtide - Obesity & Overweight
Phase 2Not yet recruitingLumos Pharma2022027-02-152026-08-10
BRE-13: Mediterranean Diet
Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile, Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue, Explore the effect of MedDiet vs. Usual Diet on Lipids - Dietary Assessment, Dietary and Lifestyle Behaviour Change
Not applicableNot yet recruitingUniversity of Illinois at Chicago302027-02-152026-10-09
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Tirzepatide - Obesity / Overweight
Not yet recruitingNanjing First Hospital, Nanjing Medical University802027-02-012026-10-15
Semaglutide for Low Back Pain
Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector) - Lower Back Pain, Obesity (BMI>30)
Phase 2Not yet recruitingWashington University School of Medicine2502027-02-012026-07-28
EMBodied psychOsocial Impacts of Weight Stigma During Pregnancy (EMBODY): A Prospective Cohort Study
Weight Stigma, Pregnancy Outcomes
Not yet recruitingMonash University8002027-02-012026-10-16

Showing 20 of 13727. Sign in to see all of them.

Narrower conditions

Obesity (11397)  ·  Weight Loss (1204)  ·  Motor Activity (1154)  ·  Diabetes Mellitus, Type 2 (1124)  ·  Pediatric Obesity (1122)  ·  Obesity, Morbid (934)  ·  Diabetes Mellitus (827)  ·  Insulin Resistance (790)  ·  Metabolic Syndrome (733)  ·  Hypertension (589)  ·  Cardiovascular Diseases (482)  ·  Inflammation (325)  ·  Body Weight (297)  ·  Obesity, Abdominal (292)

Broader conditions

Nutritional and Metabolic Diseases (13706)  ·  Overnutrition (13686)  ·  Nutrition Disorders (13624)  ·  Pathological Conditions, Signs and Symptoms (13605)  ·  Signs and Symptoms (13570)  ·  Body Weight (13262)  ·  Metabolic Diseases (3293)  ·  Glucose Metabolism Disorders (3102)  ·  Endocrine System Diseases (2253)  ·  Behavior (2109)  ·  Obesity (1844)  ·  Hyperinsulinism (1369)  ·  Body Weight Changes (1341)  ·  Diabetes Mellitus (1242)

Interventions

Exercise (496)  ·  Diet (238)  ·  semaglutide (226)  ·  Bariatric Surgery (164)  ·  Tirzepatide (150)  ·  Liraglutide (127)  ·  Metformin (125)  ·  Gastric Bypass (117)  ·  Caloric Restriction (109)  ·  Nutrition Assessment (99)  ·  Control Groups (90)  ·  Resistance Training (85)  ·  Diet Therapy (81)  ·  Standard of Care (73)  ·  Sodium Chloride (72)

Sponsors

Novo Nordisk A/S (205)  ·  University of Colorado, Denver (119)  ·  Eli Lilly and Company (118)  ·  Mayo Clinic (113)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (104)  ·  Washington University School of Medicine (95)  ·  Pennington Biomedical Research Center (91)  ·  The Miriam Hospital (91)  ·  Maastricht University Medical Center (89)  ·  University of Copenhagen (89)  ·  Massachusetts General Hospital (87)  ·  University of Alabama at Birmingham (84)  ·  Yale University (82)  ·  Duke University (80)  ·  University of Pennsylvania (79)

Countries

United States (5569)  ·  Canada (658)  ·  China (651)  ·  France (586)  ·  United Kingdom (511)  ·  Spain (479)  ·  Turkey (Türkiye) (441)  ·  Italy (411)  ·  Denmark (401)  ·  Germany (381)  ·  Brazil (323)  ·  Netherlands (292)  ·  Mexico (240)  ·  Egypt (229)  ·  Sweden (228)

Top investigators

Samuel Klein, MD (22)  ·  Jack A Yanovski, M.D. (20)

Results publications

PMID 38375882, PMID 33512717, PMID 29718281, PMID 38376518, PMID 26210388, PMID 26708836, PMID 30122305, PMID 30230252, PMID 33238176, PMID 40839263, PMID 41029405, PMID 28386912, PMID 28950422, PMID 30651576, PMID 33782940, PMID 38271099, PMID 42014131, PMID 22085317, PMID 23987123, PMID 24500151, PMID 24570244, PMID 26599819, PMID 27482610, PMID 27817208, PMID 28473337, PMID 31004409, PMID 32002540, PMID 32909523, PMID 33567185, PMID 37652841, PMID 38698650, PMID 39226070, PMID 39952695, PMID 40705619, PMID 11832527, PMID 15479938, PMID 17715408, PMID 18673303, PMID 19858703, PMID 20573639, PMID 20798995, PMID 21932999, PMID 22449319, PMID 22963820, PMID 23661689, PMID 23703580, PMID 24586896, PMID 25343235, PMID 26132939, PMID 26418188

NIH funding

2025 (56), 2023 (38), 2017 (26), 2019 (22), 2018 (16), 2014 (15), 2015 (15), 2016 (14), 2009 (13), 2008 (11), UL1TR001082 (9), P50MD017338 (6), R01DK059853 (6), UL1TR000135 (6), 2005 (5)